Cancer-Critical Genes II: Tumor Suppressor Genes
Cancer-Critical Genes II: Tumor Suppressor Genes
MicroRNAs
MicroRNAs
Experimental RNAi
siRNA - Small Interfering RNAs
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 20, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Pratibha V Nerurkar1, Vivek R Nerurkar
1Laboratory of Metabolic Disorders and Alternative Medicine, Dept. of Molecular Biosciences and Bioengineering (MBBE), CTAHR, , University of Hawaii, Honolulu.
Sirtuin activators show promise for metabolic disorders and aging. However, inhibiting sirtuin 1 (SIRT1) may benefit cancer treatment and fragile X syndrome by modulating cell death and gene expression.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: